Hims & Hers drops its compounded copy of Novo's Wegovy pill two days after launch

Hims announced a compounded semaglutide pill on February 5, 2026, priced as a low-cost alternative to Novo Nordisk's Wegovy pill. It dropped the plan on February 7 and said it would stop offering access to the treatment. The reversal came as regulators tightened their stance on compounded GLP-1 drugs.

• Planned price was $49 for the first month and $99 a month after that, against $149 a month for Novo's Wegovy pill.
• The product was pulled two days after it was announced.
• The reversal came as regulators and Novo Nordisk pressed their challenge to compounded GLP-1 copies.